Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Sala, E.; Zhou, Q.; Iasonos, A.; DeLair, D.; Hyman, D. M.; Aghajanian, C.
    International Journal of Gynecological Cancer (2014)

    Fulltext@MSK | Save
  • Better therapeutic trials in ovarian cancer
    Journal Article

    Bookman, M. A.; Gilks, C. B.; Kohn, E. C.; Kaplan, K. O.; Huntsman, D.; Aghajanian, C.; Birrer, M. J.; Ledermann, J. A.; Oza, A. M.; Swenerton, K. D.
    JNCI: Journal of the National Cancer Institute (2014)

    Fulltext@MSK | Save
  • Clinical cancer advances 2013: Annual report on progress against cancer from the American Society of Clinical Oncology
    Journal Article

    Patel, J. D.; Krilov, L.; Adams, S.; Aghajanian, C.; Basch, E.; Brose, M. S.; Carroll, W. L.; de Lima, M.; Gilbert, M. R.; Kris, M. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Independent radiologic review: Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer
    Journal Article

    Aghajanian, C.; Goff, B.; Nycum, L. R.; Wang, Y.; Husain, A.; Blank, S.
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save
  • Polyvalent vaccine-KLH conjugate and OPT-821 with bevacizumab (BEV) in patients with ovarian cancer in second or greater remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Iasonos, A.; Zhou, Q.; Durany, R.; Aghajanian, C.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II, two-stage, two-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer (EC)
    Meeting Abstract

    Myers, A. P.; Broaddus, R.; Makker, V.; Konstantinopoulos, P. A.; Drapkin, R.; Horowitz, N. S.; Liu, J.; Van Hummelen, P.; Meric-Bernstam, F.; Birrer, M. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma (UCS) with rhabdomyosarcoma (RMS) differentiation
    Meeting Abstract

    Makker, V.; Kravetz, S. J.; Gallagher, J.; Orodel, O.; Iasonos, A.; DeLair, D.; Zhou, Q.; Aghajanian, C.; Hensley, M. L.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase I data by the Gynecologic Oncology Group
    Meeting Abstract

    Monk, B. J.; Brady, W. E.; Lankes, H. A.; Facciabene, A.; Manjarrez, K.; Hershberg, R. M.; Fracasso, P. M.; Bell-McGuinn, K. M.; Walker, J. L.; McCourt, C. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of live-attenuated Listeria monocytogenes immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265)
    Meeting Abstract

    King Huh, W.; Brady, W. E.; Moore, K. N.; Lankes, H. A.; Monk, B. J.; Aghajanian, C.; Dizon, D. S.; Fracasso, P. M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Bevacizumab (Bev) for treatment of recurrent serous borderline (SB) or low-grade serous (LGS) ovarian cancer: A retrospective review of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Grisham, R. N.; Sala, E.; Zhou, Q.; Iasonos, A.; DeLair, D.; Iyer, G.; Hyman, D. M.; Spriggs, D. R.; Aghajanian, C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save